PSTPIP2 ameliorates aristolochic acid nephropathy by suppressing interleukin-19-mediated neutrophil extracellular trap formation
C. Du, J. Dong, C. Xu, P. Jia, N. Cai, Q. Wang, Z. Zhang, L. Jiang, W. Jiang, R. Feng, J. Li, C. Huang, T. Ma
This study shows PSTPIP2 reduces kidney damage in AAN by suppressing IL-19-mediated NET formation and inflammation.
bioRxiv · Jul 24, 2023Pharmacology & Toxicology